Identification and Screening of Novel Antimicrobial Peptides from Medicinal Leech via Heterologous Expression in .

The growing threat of infectious diseases requires novel therapeutics with different mechanisms of action. Antimicrobial peptides (AMPs), which are crucial for innate immunity, are a promising research area. The medicinal leech () is a potential source of bioactive AMPs that are vital while interacting with microorganisms. This study aims to investigate the antimicrobial properties of peptides found in the genome using a novel high-throughput screening method based on the expression of recombinant AMP genes in . This approach enables the direct detection of AMP activity within cells, skipping the synthesis and purification steps, while allowing the simultaneous analysis of multiple peptides. The application of this method to the first identified candidate AMPs from resulted in the discovery of three novel peptides: LBrHM1, NrlHM1 and NrlHM2. These peptides, which belong to the lumbricin and macin families, exhibit significant activity against . Two fragments of the new LBrHM1 homologue were synthesised and studied: a unique N-terminal fragment (residues 1-23) and a fragment (residues 27-55) coinciding with the active site of lumbricin I. Both fragments exhibited antimicrobial activity in a liquid medium against . Notably, the N-terminal fragment lacks homologues among previously described AMPs.